RTOG‐0129 risk groups are reproducible in a prospective multicenter heterogeneously treated cohort-Reference-Cited by-同舟云学术

RTOG‐0129 risk groups are reproducible in a prospective multicenter heterogeneously treated cohort

Published:2021-06-18 Issue:19 Volume:127 Page:3523-3530
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Fakhry Carole¹²^ORCID,Tewari Sakshi R.²^ORCID,Zhang Lisa¹,Windon Melina J.¹^ORCID,Bigelow Elaine O.¹^ORCID,Drake Virginia E.¹^ORCID,Rooper Lisa M.³,Troy Tanya²,Ha Patrick⁴,Miles Brett A.⁵,Mydlarz Wojciech K.¹,Eisele David W.¹,D’Souza Gypsyamber²^ORCID

Affiliation:

1. Department of Otolaryngology‐Head and Neck Surgery Johns Hopkins Hospital Baltimore Maryland

2. Department of Epidemiology Johns Hopkins Bloomberg School of Public Health Baltimore Maryland

3. Department of Pathology Johns Hopkins University School of Medicine Baltimore Maryland

4. Department of Otolaryngology Head and Neck Surgery University of California San Francisco California

5. Department of Otolaryngology Head and Neck Surgery Icahn School of Medicine at Mount Sinai New York New York

Funder

National Institute of Dental and Craniofacial Research

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33682

Reference22 articles.

1. HPV-associated head and neck cancer: a virus-related cancer epidemic

2. Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial

3. Prognostic Significance of p16INK4Aand Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial

4. Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial

5. Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of factors associated with positive surgical margins and the five-year survival rate after prostate cancer resection and predictive modeling;Frontiers in Oncology;2024-06-06